Translation of "Pyrexia" in German

The most commonly reported adverse reaction was pyrexia.

The most frequently reported systemic ARs were headache, fatigue and pyrexia.

The incidence and severity of pyrexia are increased with combination therapy.

Pyrexia can occur after the injection, which usually subsides spontaneously.

The most common symptoms have been rigors, headache, nausea, pyrexia, flushing and fatigue.

The most common adverse reactions are somnolence, decreased appetite, diarrhoea, pyrexia, fatigue, and vomiting.

The most frequent TEAEs in the catumaxomab group were anaemia, pyrexia, SIRS and abdominal pain.

Clinical signs in the acute phase are anaemia, pyrexia, jaundice and sudden weakness.

4 preceded, by flu-like systemic signs and symptoms including malaise, pyrexia, nausea, myalgias and rigors.

Post-marketing experience of infusion associated reactions revealed reporting of pyrexia, chills and vomiting, mostly mild to moderate in intensity.

In patients under five years of age, the very common side effects are increased blood pressure, decreased oxygen saturation (a measure of lung function), tachycardia (fast heart rate), pyrexia and chills.

In the Phase III study in STEMI patients, the most commonly reported non-bleeding adverse events (reported in at least 1% of subjects on fondaparinux) were atrial fibrillation, pyrexia, chest pain, headache, ventricular tachycardia, vomiting, and hypotension.

The most common side effects with Avonex (seen in more than 1 patient in 10) are headache, flu-like symptoms, pyrexia (fever), chills and sweating.

The most common side effect with Bondronat (seen in more than 1 patient in 10) is pyrexia (rise in body temperature).

During clinical trials, the most common infusion-related reactions included cutaneous reactions (rash, pruritus, urticaria), pyrexia, headache, hypertension, and flushing.

The most common side effects with Elaprase (seen in more than 1 in 10 patients) were related to the infusion, including skin reactions (rash or itching), pyrexia (fever), headache, hypertension (high blood pressure) and swelling at the site of the infusion.

Those most frequently reported were nausea (61% of patients), vomiting (61%), febrile neutropenia (32%), headache (24%), pyrexia (21%), pruritus (21%) and dermatitis (20%).

The most common side effects with Flebogammadif (seen in between 1 and 10 patients in 100) are headache, pyrexia (fever) and injection site reactions (pain and inflammation at the site of injection).

In studies, the most common side effects with Gardasil (seen in more than 1 patient in 10) were pyrexia (fever) and reactions at the site of the injection (redness, pain and swelling).

The most common side effects with Mycamine (seen in between 1 and 10 patients in 100) are leucopenia (low levels of leucocytes, a type of white blood cell), neutropenia (low levels of neutrophils, a type of white blood cell), anaemia (low red blood cell counts), hypokalaemia (low blood potassium levels), hypomagnesaemia (low blood magnesium levels), hypocalcaemia (low blood calcium levels), headache, phlebitis (inflammation of a vein), nausea (feeling sick), vomiting, diarrhoea, abdominal (tummy) pain, signs of liver problems in the blood (increased levels of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase or bilirubin), rash, pyrexia (fever) and rigors (shaking chills).

During the studies, the most common side effects with Myozyme (seen in more than 1 patient in 10) were tachycardia (rapid heart rate), flushing (redness), cough, tachypnoea (rapid breathing rate), vomiting, urticaria (hives), rash, pyrexia (fever) and decreased oxygen saturation (low oxygen levels in the blood).